Medline (MDLN) EBIT Margin (2025 - 2026)
Medline (MDLN) reported EBIT Margin of 5.74% for Q1 2026, down 285.0% year-over-year from 3.1% in Q1 2025, and down 33.21% on a QoQ basis from 8.59% in Q1 2025.
Medline (MDLN) has 2 years of EBIT Margin data on file, last reported at 5.74% in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 146.28 Bn | 141.88 Bn | 1.83 Bn | 30.87% |
| 2 | Becton Dickinson | 41.14 Bn | 40.13 Bn | 2.15 Bn | 1.97% |
| 3 | Medline | 29.16 Bn | 35.00 Bn | 1.84 Bn | 5.74% |
| 4 | Resmed | 27.13 Bn | 25.47 Bn | 890.98 Mn | 34.92% |
| 5 | West Pharmaceutical Services | 22.71 Bn | 22.19 Bn | 296.40 Mn | 20.96% |
| 6 | Solventum | 13.26 Bn | 13.26 Bn | 1.10 Bn | 4.04% |
| 7 | Align Technology | 12.22 Bn | 11.16 Bn | 736.59 Mn | 13.65% |
| 8 | Cooper Companies | 11.79 Bn | 11.66 Bn | 695.20 Mn | 20.78% |
| 9 | Baxter International | 9.47 Bn | 7.42 Bn | 891.00 Mn | 2.44% |
| 10 | Aptargroup | 7.19 Bn | 6.99 Bn | 351.91 Mn | 10.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 5.74% |
| Mar 29, 2025 | 8.59% |